首页> 外文期刊>American Journal of Sports Medicine >The use of drugs and nutritional supplements in top-level track and field athletes.
【24h】

The use of drugs and nutritional supplements in top-level track and field athletes.

机译:在顶级田径运动员中使用药物和营养补品。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: High use of medication and nutritional supplements has been reported in several sports. PURPOSE: To document the use of prescribed medication and nutritional supplements in female and male junior, youth, and adult track and field athletes depending on their sports discipline. STUDY DESIGN: Descriptive epidemiology study. METHODS: Analysis of 3 887 doping control forms undertaken during 12 International Association of Athletics Federations World Championships and 1 out-of-competitions season in track and field. RESULTS: There were 6 523 nutritional supplements (1.7 per athlete) and 3 237 medications (0.8 per athlete) reported. Nonsteroidal anti-inflammatory drugs (NSAIDs; 0.27 per athlete, n = 884), respiratory drugs (0.21 per athlete, n = 682), and alternative analgesics (0.13, n = 423) were used most frequently. Medication use increased with age (0.33 to 0.87 per athlete) and decreased with increasing duration of the event (from sprints to endurance events; 1.0 to 0.63 per athlete). African and Asian track and field athletes reported using significantly fewer supplements (0.85 vs 1.93 per athlete) and medications (0.41 vs 0.96 per athlete) than athletes from other continents. The final ranking in the championships was unrelated to the quantity of reported medications or supplements taken. Compared with middle-distance and long-distance runners, athletes in power and sprint disciplines reported using more NSAIDs, creatine, and amino acids, and fewer antimicrobial agents. CONCLUSION: The use of NSAIDs in track and field is less than that reported for team-sport events. However, nutritional supplements are used more than twice as often as they are in soccer and other multisport events; this inadvertently increases the risk of positive results of doping tests. CLINICAL RELEVANCE: It is essential that an evidence-based approach to the prescribing of medication and nutritional supplements is adopted to protect the athletes' health and prevent them from testing positive in doping controls.
机译:背景:在一些运动中已报道药物和营养补充剂的大量使用。目的:记录根据年龄,性别而定的男女田径,青年和成年田径运动员处方药和营养补充剂的使用情况。研究设计:描述性流行病学研究。方法:分析了在12届国际田径联合会世界锦标赛和1项田径比赛以外的季节中进行的3 887次兴奋剂控制形式。结果:报告了6 523份营养补充剂(每位运动员1.7)和3 237种药物(每位运动员0.8)。非甾体类抗炎药(NSAID;每名运动员0.27,n = 884),呼吸道药物(每名运动员0.21,n = 682)和其他镇痛药(0.13,n = 423)被最常使用。药物使用随着年龄的增长而增加(每位运动员0.33至0.87),并且随着事件持续时间的增加而减少(从短跑到耐力事件;每位运动员1.0至0.63)。非洲和亚洲田径运动员报告使用的补品(每位运动员0.85比1.93)和药物(每位运动员0.41比0.96)明显少于其他大洲的运动员。锦标赛的最终排名与所报告的药物或补品的服用量无关。与中长跑运动员相比,力量和冲刺学科的运动员报告使用的是更多的NSAID,肌酸和氨基酸,并且使用的抗菌剂更少。结论:田径运动中使用非甾体抗炎药的数量少于团体运动项目中的报告。但是,营养补品的使用频率是足球和其他多项运动项目中使用频率的两倍以上。这在无意中增加了兴奋剂测试阳性结果的风险。临床相关性:采取基于证据的药物和营养补充剂处方方法至关重要,以保护运动员的健康,并防止他们在兴奋剂控制中检测出阳性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号